TiUltra Implant Study
Comparison of Early Healing Dynamics Between NobelActive S TiUltra and NobelReplace CC Ti Unite Implants Using Resonance Frequency Analysis: A Prospective Clinical Study
This prospective clinical study will compare early healing and implant stability between two Nobel Biocare dental implant systems, NobelActive S TiUltra and NobelReplace CC TiUnite. Approximately 30 implants will be randomly assigned to one of the two implant groups and followed for 12 weeks after placement. Implant stability will be assessed using resonance frequency analysis at implant placement and at approximately 2, 4, 6, 8, and 12 weeks. Clinical healing, radiographic findings, and other treatment-related outcomes will also be evaluated during the follow-up period.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Fase 4
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Hanae Saito
- Telefonnummer: 410-706-3646
- E-mail: hsaito@umaryland.edu
Studiesteder
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21231
- University of Maryland School of Dentistry
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Age ≥18 years
- Male or Female
- Partially edentulous patients
- Healed ridges (≥3 months post-extraction with no history of socket preservation or ridge augmentation)
- Adequate bone volume (no need for major grafting)
- Sites requiring a single unit implant
- Provision of informed consent
Exclusion Criteria:
- Systemic or local disease or condition that would compromise bone metabolism, post-operative healing and/or osseointegration e.g. uncontrolled diabetes with self-reported most recent HbA1C > 8.0 within last six months
- Systemic corticosteroids or any other medication that would influence bone metabolism, post-operative healing, and/or osseointegration
- History of osseous degenerative diseases
- Heavy smoking (>10 cigarettes/day)
- Bisphosphonate/antiresorptive therapy
- uncontrolled periodontal disease
- Irradiated bone
- Previous history of failed implants
- Recently grafted/augmented site (< 1 year)
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Aktiv komparator: TiUnite
|
NobelReplace CC TiUnite dental implant placed according to the manufacturer's recommended surgical protocol. |
|
Eksperimentel: TiUltra
|
NobelActive S TiUltra dental implant placed according to the manufacturer's recommended surgical protocol. |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Mean Implant Stability Quotient (ISQ) Measured by Resonance Frequency Analysis (RFA)
Tidsramme: Day 0 (implant placement) and Weeks 2, 4, 6, 8, and 12
|
Implant stability will be assessed using an Osstell device/SmartPeg transducer expressed as Implant Stability Quotient (ISQ) values on a scale of 0 to 100. Longitudinal changes in ISQ will be compared between the TiUnite and S-TiUltra implant groups over the 12-week healing period to evaluate differences in implant stability trajectories. |
Day 0 (implant placement) and Weeks 2, 4, 6, 8, and 12
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Mean Implant Insertion Torque (Ncm)
Tidsramme: Day 0 (during implant placement)
|
Insertion torque will be recorded during implant placement and expressed in Newton-centimeters (Ncm). |
Day 0 (during implant placement)
|
|
Change From Baseline in Radiographic Marginal Bone Level (mm)
Tidsramme: Day 0 (baseline) and Weeks 6 and 12
|
Marginal bone levels in millimeters (mm) will be assessed using standardized periapical radiographs obtained at implant placement (baseline) and at 6 and 12 weeks after surgery. |
Day 0 (baseline) and Weeks 6 and 12
|
|
Number of Participants With Implant Failure
Tidsramme: From Day 0 (implant placement) through Week 12
|
Implant-related complications, including implant failure and marginal bone loss, will be assessed during the 12-week follow-up period. |
From Day 0 (implant placement) through Week 12
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- HP-00120517
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .